structure given in first source; reduces myocardial infarct size, MPO activity, and the activity of arachidonic acid, thromboxane B2 synthesis, plasma glutamate oxalo-acetate transaminase, lactate dehydrogenase, and creatine kinase
Also Known As:
2-methyl-3-(1,4,5,6-tetrahydronicotinoyl)pyrazolo(1,5-a)pyridine; KC-764